Bath & Body Works, Inc. (NYSE:BBWI) Stock Holdings Increased by AQR Capital Management LLC

AQR Capital Management LLC boosted its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 55.8% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 124,333 shares of the company’s stock after purchasing an additional 44,512 shares during the period. AQR Capital Management LLC owned about 0.06% of Bath & Body Works worth $4,810,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of Bath & Body Works by 28.1% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 258,617 shares of the company’s stock valued at $12,936,000 after acquiring an additional 56,764 shares in the last quarter. Russell Investments Group Ltd. increased its position in Bath & Body Works by 46.9% in the 1st quarter. Russell Investments Group Ltd. now owns 131,605 shares of the company’s stock worth $6,572,000 after purchasing an additional 41,995 shares during the last quarter. Vanguard Group Inc. increased its position in Bath & Body Works by 4.2% in the 1st quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock worth $1,370,458,000 after purchasing an additional 1,102,124 shares during the last quarter. SG Americas Securities LLC raised its stake in shares of Bath & Body Works by 968.1% during the 1st quarter. SG Americas Securities LLC now owns 190,758 shares of the company’s stock worth $9,542,000 after purchasing an additional 172,898 shares in the last quarter. Finally, Cibc World Markets Corp lifted its holdings in shares of Bath & Body Works by 38.6% during the 4th quarter. Cibc World Markets Corp now owns 57,040 shares of the company’s stock valued at $2,462,000 after buying an additional 15,895 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Price Performance

Shares of Bath & Body Works stock opened at $29.92 on Friday. The company has a market cap of $6.68 billion, a PE ratio of 7.71, a price-to-earnings-growth ratio of 0.96 and a beta of 1.77. The firm has a fifty day moving average price of $31.39 and a two-hundred day moving average price of $39.78. Bath & Body Works, Inc. has a fifty-two week low of $26.20 and a fifty-two week high of $52.99.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The business had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Analysts expect that Bath & Body Works, Inc. will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 6th. Investors of record on Friday, August 23rd were paid a $0.20 dividend. The ex-dividend date was Friday, August 23rd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.67%. Bath & Body Works’s payout ratio is 20.62%.

Analysts Set New Price Targets

Several brokerages recently weighed in on BBWI. Citigroup cut their price objective on shares of Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating on the stock in a research report on Tuesday, August 20th. Wells Fargo & Company decreased their price objective on shares of Bath & Body Works from $48.00 to $40.00 and set an “equal weight” rating for the company in a report on Wednesday, July 24th. Morgan Stanley lowered their target price on shares of Bath & Body Works from $56.00 to $51.00 and set an “overweight” rating on the stock in a research report on Thursday, September 5th. Barclays decreased their price target on Bath & Body Works from $32.00 to $31.00 and set an “equal weight” rating for the company in a research note on Thursday, August 29th. Finally, The Goldman Sachs Group lowered their price objective on Bath & Body Works from $60.00 to $49.00 and set a “buy” rating on the stock in a report on Thursday, August 29th. Eight equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $42.35.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.